Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.

Source:http://linkedlifedata.com/resource/pubmed/id/21306953

Download in:

View as

General Info

PMID
21306953